Interpace Diagnostics Group, Inc.(IDXG) - 2025 Q4 - Annual Results
Interpace Diagnostics Group, Inc.(US:IDXG)2026-01-20 14:05Financial Performance - Interpace Biosciences, Inc. announced preliminary and unaudited revenue for the year ended December 31, 2025[4] Corporate Actions - The company converted all outstanding shares of its Series C Preferred Stock into common stock[5] Press Release - The press release detailing these updates was issued on January 20, 2026[4]